Stocks · News reference
Autonomix Medical is skyrocketing Tuesday after securing U.S. Patent No. 12,433,670, expanding protection for its nerve-mapping platform.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-26 AccNo: 0001437749-26-029024 Size: 545 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarU.S. Patent No. 12,714,780 by the United States Patent and Trademark Office (USPTO), titled "Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development" on August 25,
Read original at benzingaGainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2 earnings report
Read original at benzingaAMIX: 126% | Autonomix Medical shares are trading higher ahead of the Patent and Trademark Office's decision to grant the company U.S. Patent No. 12,714,780 titled "Systems and Methods for Regulating Organ
Read original at benzinga